Does the conventional landmark help to place the tip of REBOA catheter in the optimal position? A non-controlled comparison study

Springer Science and Business Media LLC - Tập 14 - Trang 1-8 - 2019
Kento Nakajima1,2, Hayato Taniguchi2,3, Takeru Abe1,2, Keishi Yamaguchi1,2, Tomoki Doi2,4, Ichiro Takeuchi1,2, Naoto Morimura5
1Advanced Critical Care and Emergency Center, Yokohama City University Medical Center, Yokohama, Japan
2Department of Emergency Medicine, Graduate School of Medicine, Yokohama City University, Yokohama, Japan
3Department of Surgery Intensive Care, Nippon Medical School Hospital, Tokyo, Japan
4Critical Care and Emergency Center, Yokosuka Kyosai Hospital, Yokosuka, Japan
5Department of Acute Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Tóm tắt

Resuscitative endovascular balloon occlusion of the aorta (REBOA) for patients with traumatic torso hemorrhagic shock is available to keep a minimum level of circulatory status as a bridge to definitive therapy. However, the trajectory for placement of REBOA in the aorta has not yet been clearly defined. We conducted a retrospective observational cohort study in the two tertiary critical care and emergency center from December 2014 to October 2018. A total of 28 patients who underwent focused assessment with sonography for trauma (FAST) were studied via contrast computed tomography (CT), and 27 were analyzed. We divided patients into two groups based on our CT findings. The REBOA deflate group included 16 patients, and the inflate group included 11 patients. The median trace value (interquartile range) of the blood vessel center line from the common femoral artery to the tip of REBOA (blood vessel length) and the length of REBOA itself from the common femoral artery to the tip of REBOA (REBOA insertion length) were 56.2 cm (54.5–57.2) and 55.2 cm (54.2–55.6), respectively (p < 0.0001) for the deflated group, and 51.4 cm (42.1–56.6) and 50.3 cm (42.3–55.0) (p = 0.594), respectively, for the inflated group. If REBOA was deflated, it was placed 1.0 cm longer than the insertion length of REBOA catheter itself, but that was not the case when inflating REBOA. The individual difference was large to the extent that the balloon inflated and the extent to which the balloon was pushed back toward the caudal depending on the degree of blood pressure. Further studies would be needed to validate the study findings.

Tài liệu tham khảo

Pezy P, Flaris AN, Prat NJ, et al. Fixed-distance model for balloon placement during fluoroscopy-free resuscitative endovascular balloon occlusion of the aorta in a civilian population. JAMA Surg. 2017;152:351–8. Gamberini E, Coccolini F, Tamagnini B, et al. Resuscitative endovascular balloon occlusion of the aorta in trauma: a systematic review of the literature. World J Emerg Surg. 2017;12:42. Davis JS, Satahoo SS, Butler FK, et al. An analysis of prehospital deaths: who can we save? J Trauma Acute Care Surg. 2014;77:213–8. Morrison JJ, Ross JD, Houston R, Watson JD, Sokol KK, Rasmussen TE. Use of resuscitative endovascular balloon occlusion of the aorta in a highly lethal model of noncompressible torso hemorrhage. Shock (Augusta, Ga). 2014;41:130–7. Tsurukiri J, Akamine I, Sato T, et al. Resuscitative endovascular balloon occlusion of the aorta for uncontrolled haemorrhagic shock as an adjunct to haemostatic procedures in the acute care setting. Scandinavian journal of trauma, resuscitation and emergency medicine. 2016;24:13. Tien HC, Spencer F, Tremblay LN, Rizoli SB, Brenneman FD. Preventable deaths from hemorrhage at a level I Canadian trauma center. The Journal of trauma. 2007;62:142–6. Bansal V, Fortlage D, Lee JG, Costantini T, Potenza B, Coimbra R. Hemorrhage is more prevalent than brain injury in early trauma deaths: the golden six hours. European journal of trauma and emergency surgery: official publication of the European Trauma Society. 2009;35:26–30. Inoue J, Shiraishi A, Yoshiyuki A, Haruta K, Matsui H, Otomo Y. Resuscitative endovascular balloon occlusion of the aorta might be dangerous in patients with severe torso trauma: a propensity score analysis. J Trauma Acute Care Surg. 2016;80:559–66 discussion 66-7. Moore LJ, Martin CD, Harvin JA, Wade CE, Holcomb JB. Resuscitative endovascular balloon occlusion of the aorta for control of noncompressible truncal hemorrhage in the abdomen and pelvis. American journal of surgery. 2016;212:1222–30. Norii T, Crandall C, Terasaka Y. Survival of severe blunt trauma patients treated with resuscitative endovascular balloon occlusion of the aorta compared with propensity score-adjusted untreated patients. J Trauma Acute Care Surg. 2015;78:721–8. Brenner M, Teeter W, Hoehn M, et al. Use of resuscitative endovascular balloon occlusion of the aorta for proximal aortic control in patients with severe hemorrhage and arrest. JAMA Surg. 2018;153:130–5. King DR. Initial care of the severely injured patient. The New England journal of medicine. 2019;380:763–70. Linnebur M, Inaba K, Haltmeier T, et al. Emergent non-image-guided resuscitative endovascular balloon occlusion of the aorta (REBOA) catheter placement: a cadaver-based study. J Trauma Acute Care Surg. 2016;81:453–7. Okada Y, Narumiya H, Ishi W, Iiduka R. Anatomical landmarks for safely implementing resuscitative balloon occlusion of the aorta (REBOA) in zone 1 without fluoroscopy. Scandinavian journal of trauma, resuscitation and emergency medicine. 2017;25:63. MacTaggart JN, Poulson WE, Akhter M, et al. Morphometric roadmaps to improve accurate device delivery for fluoroscopy-free resuscitative endovascular balloon occlusion of the aorta. J Trauma Acute Care Surg. 2016;80:941–6. Wessels LE, Wallace JD, Bowie J, Butler WJ, Spalding C, Krzyzaniak M. Radiofrequency identification of the ER-REBOA: confirmation of placement without fluoroscopy. Military medicine. 2018. Yokohama city homepage. http://www.city.yokohama.lg.jp/ex/stat/jinko/news-e.html. Accessed 1 Jan 2019. Yokosuka city homepage. https://www.city.yokosuka.kanagawa.jp/0830/data/toukei/suikei/now.html. Accessed 1 Jan 2019. Zushi city homepage. https://www.city.zushi.kanagawa.jp/syokan/kikaku/population-data.html. Accessed 1 Jan 2019. Miura city homepage. http://www.city.miura.kanagawa.jp/hisho/eng/ information.html. Accessed 1 Jan 2019. van der Burg BLS B, van Dongen T, Morrison JJ, et al. A systematic review and meta-analysis of the use of resuscitative endovascular balloon occlusion of the aorta in the management of major exsanguination. European journal of trauma and emergency surgery: official publication of the European Trauma Society. 2018;44:535–50. Stannard A, Eliason JL, Rasmussen TE. Resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct for hemorrhagic shock. The Journal of trauma. 2011;71:1869–72. Sato R, Kuriyama A, Takaesu R, et al. Resuscitative endovascular balloon occlusion of the aorta performed by emergency physicians for traumatic hemorrhagic shock: a case series from Japanese emergency rooms. Critical care (London, England). 2018;22:103. Cheema F, Garcia C, Rivera AG, Chao E. CE: The use of resuscitative endovascular balloon occlusion of the aorta in treating hemorrhagic shock from severe trauma. The American journal of nursing. 2018;118:22–8. Hoehn MR, Hansraj NZ, Pasley AM, et al. Resuscitative endovascular balloon occlusion of the aorta for non-traumatic intra-abdominal hemorrhage. European journal of trauma and emergency surgery: official publication of the European Trauma Society. 2018. Zakaluzny SA, Beldowicz BC, Salcedo ES, JJ DB, Moore LJ, Brenner M. Guidelines for a system-wide multi-disciplinary approach to institutional REBOA implementation. J Trauma Acute Care Surg. 2018. Baker SP, O'Neill B, Haddon W Jr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. The Journal of trauma. 1974;14:187–96. Richardson R, Adcock L. CADTH Rapid Response Reports. Resuscitative endovascular balloon occlusion of the aorta for control of non-compressible truncal hemorrhage: a review of clinical effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health. Copyright © 2018 Canadian Agency for Drugs and Technologies in Health; 2018.